154 related articles for article (PubMed ID: 15073941)
1. Potential utility of electronic drug compliance monitoring in measures of adverse outcomes associated with immunosuppressive agents.
Feldman HI; Hackett M; Bilker W; Strom BL
Pharmacoepidemiol Drug Saf; 1999 Jan; 8(1):1-14. PubMed ID: 15073941
[TBL] [Abstract][Full Text] [Related]
2. Patient compliance in rheumatoid arthritis, polymyalgia rheumatica, and gout.
de Klerk E; van der Heijde D; Landewé R; van der Tempel H; Urquhart J; van der Linden S
J Rheumatol; 2003 Jan; 30(1):44-54. PubMed ID: 12508389
[TBL] [Abstract][Full Text] [Related]
3. Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use.
Robin AL; Novack GD; Covert DW; Crockett RS; Marcic TS
Am J Ophthalmol; 2007 Oct; 144(4):533-40. PubMed ID: 17686450
[TBL] [Abstract][Full Text] [Related]
4. Acute rejection in non-compliant renal allograft recipients: a distinct morphology.
Lerut E; Kuypers DR; Verbeken E; Cleutjens J; Vlaminck H; Vanrenterghem Y; Van Damme B
Clin Transplant; 2007; 21(3):344-51. PubMed ID: 17488383
[TBL] [Abstract][Full Text] [Related]
5. [Cross-national comparison of drug compliance and non-compliance associated factors in the elderly with polypharmacotherapy].
Topinková E; Fialová D; Carpenter GI; Bernabei R
Cas Lek Cesk; 2006; 145(9):726-32. PubMed ID: 17091729
[TBL] [Abstract][Full Text] [Related]
6. The compliance-questionnaire-rheumatology compared with electronic medication event monitoring: a validation study.
de Klerk E; van der Heijde D; Landewé R; van der Tempel H; van der Linden S
J Rheumatol; 2003 Nov; 30(11):2469-75. PubMed ID: 14677194
[TBL] [Abstract][Full Text] [Related]
7. Patterns of drug compliance with medications to be taken once and twice daily assessed by continuous electronic monitoring in primary care.
Kruse W; Rampmaier J; Ullrich G; Weber E
Int J Clin Pharmacol Ther; 1994 Sep; 32(9):452-7. PubMed ID: 7820327
[TBL] [Abstract][Full Text] [Related]
8. The DIACOM study (effect of DosIng frequency of oral Antidiabetic agents on the COMpliance and biochemical control of type 2 diabetes).
Kardas P
Diabetes Obes Metab; 2005 Nov; 7(6):722-8. PubMed ID: 16219016
[TBL] [Abstract][Full Text] [Related]
9. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
10. Medication noncompliance in patients with chronic disease: issues in dialysis and renal transplantation.
Loghman-Adham M
Am J Manag Care; 2003 Feb; 9(2):155-71. PubMed ID: 12597603
[TBL] [Abstract][Full Text] [Related]
11. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
12. Report from the National Transplantation Pregnancy Registry: outcomes of pregnancy after transplantation.
Armenti VT; Daller JA; Constantinescu S; Silva P; Radomski JS; Moritz MJ; Gaughan WJ; McGrory CH; Coscia LA
Clin Transpl; 2006; ():57-70. PubMed ID: 18368705
[TBL] [Abstract][Full Text] [Related]
13. Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana.
Vriesendorp R; Cohen A; Kristanto P; Vrijens B; Rakesh P; Anand B; Iwebor HU; Stiekema J
Eur J Clin Pharmacol; 2007 Dec; 63(12):1115-21. PubMed ID: 17882408
[TBL] [Abstract][Full Text] [Related]
14. Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study.
Okeke CO; Quigley HA; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Friedman DS
Ophthalmology; 2009 Feb; 116(2):191-9. PubMed ID: 19084273
[TBL] [Abstract][Full Text] [Related]
15. Symptom experience associated with immunosuppressive drugs after liver transplantation in adults: possible relationship with medication non-compliance?
Drent G; Moons P; De Geest S; Kleibeuker JH; Haagsma EB
Clin Transplant; 2008; 22(6):700-9. PubMed ID: 18673378
[TBL] [Abstract][Full Text] [Related]
16. Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis.
Halpern R; Mody RR; Fuldeore MJ; Patel PA; Mikuls TR
Curr Med Res Opin; 2009 Jul; 25(7):1711-9. PubMed ID: 19485724
[TBL] [Abstract][Full Text] [Related]
17. Use of drugs with more than a twenty-four-hour duration of action.
Waeber B; Erne P; Saxenhofer H; Heynen G
J Hypertens Suppl; 1994 Nov; 12(8):S67-71. PubMed ID: 7707159
[TBL] [Abstract][Full Text] [Related]
18. Intrasubject medication adherence patterns.
Russell CL; Conn VS; Ashbaugh C; Madsen R; Hayes K; Ross G
Clin Nurs Res; 2007 May; 16(2):153-63. PubMed ID: 17452433
[TBL] [Abstract][Full Text] [Related]
19. Limitations of cyclosporine C2 monitoring in pediatric heart transplant recipients.
Hmiel SP; Canter C; Shepherd R; Lassa-Claxton S; Nadler M
Pediatr Transplant; 2007 Aug; 11(5):524-9. PubMed ID: 17631021
[TBL] [Abstract][Full Text] [Related]
20. Impact of supportive measures on drug adherence in patients with essential hypertension treated with valsartan: the randomized, open-label, parallel group study VALIDATE.
Düsing R; Handrock R; Klebs S; Tousset E; Vrijens B
J Hypertens; 2009 Apr; 27(4):894-901. PubMed ID: 19300114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
